Annovis Bio, Inc. (ANVS)
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease in Down Syndrome and other chronic neurodegenerative disorders. It is also developing ANVS405 for protecting the traumatic brain injury and stroke; and ANVS301, which is in Phase I clinical trials to increase cognitive capability in later stages of AD and dementia. The company was incorporated in 2008 and is based in Berwyn, Pennsylvania.
$104.43M
Dr. Maria L. Maccecchini Ph.D.
3.00
Berwyn, PA
Jan 29, 2020
-1.76
$-4.54
0.99
1.24
0.00%
-2.11
-0.02
-51.73
0.00
1.24
-852.43%
2,776.41%
Similar stocks (18)
Axsome Therapeutics, Inc.
AXSM
Iovance Biotherapeutics, Inc.
IOVA
Novavax, Inc.
NVAX
Cassava Sciences, Inc.
SAVA
Day One Biopharmaceuticals, Inc.
DAWN
Immunome, Inc.
IMNM
Terns Pharmaceuticals, Inc.
TERN
Anavex Life Sciences Corp.
AVXL
Inozyme Pharma, Inc.
INZY
Seres Therapeutics, Inc.
MCRB
Acumen Pharmaceuticals, Inc.
ABOS
Anixa Biosciences, Inc.
ANIX
Lantern Pharma Inc.
LTRN
Reviva Pharmaceuticals Holdings, Inc.
RVPH
Cue Biopharma, Inc.
CUE
IN8bio, Inc.
INAB
TFF Pharmaceuticals, Inc.
TFFP
Galera Therapeutics, Inc.
GRTX
ETF Exposure (11)
iShares Micro-Cap ETF
IWC
0.01725%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (18)
Axsome Therapeutics, Inc.
AXSM
Iovance Biotherapeutics, Inc.
IOVA
Novavax, Inc.
NVAX
Cassava Sciences, Inc.
SAVA
Day One Biopharmaceuticals, Inc.
DAWN
Immunome, Inc.
IMNM
Terns Pharmaceuticals, Inc.
TERN
Anavex Life Sciences Corp.
AVXL
Inozyme Pharma, Inc.
INZY
Seres Therapeutics, Inc.
MCRB
Acumen Pharmaceuticals, Inc.
ABOS
Anixa Biosciences, Inc.
ANIX
Lantern Pharma Inc.
LTRN
Reviva Pharmaceuticals Holdings, Inc.
RVPH
Cue Biopharma, Inc.
CUE
IN8bio, Inc.
INAB
TFF Pharmaceuticals, Inc.
TFFP
Galera Therapeutics, Inc.
GRTX
ETF Exposure (11)
iShares Micro-Cap ETF
IWC
0.01725%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%